Middle East Molecular Point of Care Testing (Using NAAT) Market Competitive Strategies, Analysis by 2029
Description
Middle
East molecular point of care testing (using NAAT) Market is expected to
reach USD 2,175.21 million by 2028, from USD 1,121.37 million in 2020, growing
at the CAGR of 7.4% in the forecast
period of 2021 to 2028.In the global pandemic, attempt to
synergize the sensitivity of NAATs and the ease of use of POCT assays,
miniaturized NAAT-based POCT devices and assays were devised for faster
screening and diagnosis of COVID-19, which also propelled the growth of the Market
.
Market
Analysis and Insights: Middle East
Molecular Point of Care Testing (Using NAAT) Market
POCT is characterized as testing
which can be done close to the patient where a medical decision can be made
immediately, including the results and monitoring. POCT devices now entering
into clinical use are based on nucleic acid amplification technologies (NAAT),
defined here as second-generation devices. These platforms generally have
improved sensitivity, typically in the range of 60 to 90%, compared to
first-generation POCTs, and require portable instrumentation with a footprint
of approximately 30cm x 30cm. These instruments are essentially used in the
molecular detection of various disorders such as HIV, HPV, and respiratory
disease through NAAT technology. NAAT is Nucleic Acid Amplification Techniques
which allows identification of pathogenic organisms by detecting their DNA or
RNA.
Molecular point-of-care testing's
significant advantages include the rapid diagnosis process, treatment choice,
monitoring, and prognosis. This will also help in operational decision-making
and proper resource utilization. The increasing prevalence of chronic disease
and increasing diagnosis-seeking rate are expected to act as drivers for the Market
. However, the high cost of POCT instruments may hinder the growth of the Market
.
This Middle East molecular point of
care testing (using NAAT) Market report
provides details of Market share, new
developments, and product pipeline analysis, the impact of domestic and localized
Market players, analyses opportunities
in terms of emerging revenue pockets, changes in Market regulations, product approvals, strategic
decisions, product launches, geographic expansions, and technological
innovations in the Market . To understand the analysis and the Market scenario, contact us for an Analyst Brief. Our
team will help you create a revenue impact solution to achieve your desired
goal.
Request Access for Middle East
Molecular Point of Care Testing (Using NAAT) Market
Sample Report: https://www.databridgeMarket research.com/request-a-sample/?dbmr=middle-east-molecular-point-of-care-testing-using-naat-Market
Middle
East Molecular Point Of Care Testing (Using NAAT) Market Scope and Market Size
· On the basis of indication, the Middle East molecular point of care
testing (using NAAT) Market is segmented
into sexually transmitted infection (STI) testing, respiratory infection
testing, gastrointestinal tract infection testing, and others. In 2021, the
respiratory segment in the molecular point of care testing (using NAAT) Market is expected to dominate because of a sudden
outbreak of COVID-19 and a rise in the incidence of various other respiratory
disorders due to the no-contact spread of the disease.
· On the basis of product, the Middle East molecular point of care testing
(using NAAT) Market is segmented into
instruments, consumables and reagents. In 2021, the consumables & reagents
segment in the molecular point of care testing (using NAAT) Market is expected to grow due to the increasing
demand for the product of molecular POCT in this region.
· On the basis of end user, the Middle East molecular point of care
testing (using NAAT) Market is segmented
into laboratories, hospitals, clinics, ambulatory centers, home care, assisted
living facilities, and others. In 2021, the laboratories segment is expected to
dominate the Market because the major
laboratories around the world are expanding their research and medical
laboratories to upgrade the medical facilities.
· On the basis of mode of testing, the Middle East molecular point of care
testing (using NAAT) Market is segmented
into prescription-based testing and OTC testing. In 2021, the
prescription-based testing segment in the molecular point of care testing
(using NAAT) Market is expected to grow
because the use of NAAT in PCOT is new and thus requires expert advice and
monitoring, which increase the Market for prescription-based testing.
· On the basis of distribution channel, the Middle East molecular point of
care testing (using NAAT) Market is
segmented into direct tender, third party distributor, online sales. In 2021,
the direct sales segment in the molecular point of care testing (using NAAT) Market
is expected to grow due to the increased
demand for advanced technologies and testing requirements in medical care for
operations and diagnosis.
Get TOC of the Report: https://www.databridgeMarket research.com/toc/?dbmr=middle-east-molecular-point-of-care-testing-using-naat-Market
Major TOC of the Middle
East Molecular Point of Care Testing (Using NAAT) Market Report
Chapter One:
MARKET SEGEMENTATION
EXECUTIVE SUMMARY
PREMIUM INSIGHTS
MARKET OVERVIEW
Access Full Report:- https://www.databridgeMarket research.com/reports/middle-east-molecular-point-of-care-testing-using-naat-Market
Middle
East Molecular Point of Care Testing (Using NAAT) Market Country Level Analysis
The country section of the report
also provides individual Market impacting factors and changes in regulation in
the Market domestically that impact the
current and future trends of the Market . Data points such as new sales,
replacement sales, country demographics, regulatory acts, and import-export
tariffs are some of the major pointers used to forecast the Market scenario for individual countries. Also, the
presence and availability of Middle East brands and their challenges faced due
to large or scarce competition from local and domestic brands, the impact of sales
channels are considered while providing forecast analysis of the country
data.
Competitive
Landscape and Molecular Point of Care Testing (Using NAAT) Market Share Analysis
Details included are
company overview, company financials, revenue generated, Market potential, investment in research and development,
new Market initiatives, production sites
and facilities, company strengths and weaknesses, product launch, product
trials pipelines, product approvals, patents, product width and breadth,
application dominance, technology lifeline curve. The above data points
provided are only related to the company's focus related to Middle East
molecular point of care testing (using NAAT).
The major companies providing molecular point of care
testing (using NAAT) products in the Middle East molecular point of care
testing (using NAAT) Market are
·
ABBOTT,
·
Hologic, Inc.,
·
F.Hoffmann-La Roche
Ltd.,
·
Meridian Bioscience,
·
Quantumdx Group
Ltd.,
·
Cardinal Health,
·
biomerieux SA,
·
Bio-Rad
Laboratories, Inc.,
·
GenMark Diagnsotics,
Inc.,
·
Grifols, S.A.,
·
QIAGEN,
·
Quidel Corporation,
·
SD Biosensor, INC.,
·
Seegene Inc., among
others.
Browse Related
Reports @
Middle
East and Africa Ethylene-Vinyl Alcohol Copolymer (EVOH) Packaging Films Market
Global
Commercial Dishwashers Market
Europe
Commercial Dishwashers Market
U.S.
Private Label Food and Beverages Market
Europe
Point-Of-Care-Testing (POCT) Market
Thailand
Point-of-Care Testing (POCT) Market
About Us:
Data Bridge Market Research set forth itself as
an unconventional and neoteric Market research and consulting firm with unparalleled
level of resilience and integrated approaches. We are determined to unearth the
best Market opportunities and foster
efficient information for your business to thrive in the Market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Comments
Post a Comment